European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Incorporating flexibility into protein-ligand docking

Objetivo

One of the major goals of current drug discovery methods is the correct treatment of the flexibility of the receptor (i.e. protein) in small ligand docking. Computer-aided drug discovery through ligand docking-based virtual screening is already a key component in the lengthy and costly process of developing new drugs not only for academy but also for the pharmaceutical industries. In this proposal, we want to incorporate flexibility considerations into structure based drug discovery by using theoretical methods such as Molecular Dynamics and Normal Mode Analysis. The approach will be a step toward the integration of dynamics in structure-based of drug discovery.

Convocatoria de propuestas

FP7-PEOPLE-2007-4-1-IOF
Consulte otros proyectos de esta convocatoria

Coordinador

FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
Aportación de la UE
€ 221 673,82
Dirección
CARRER BALDIRI REIXAC 10-12 PARC SCIENTIFIC DE BARCELONA
08028 Barcelona
España

Ver en el mapa

Región
Este Cataluña Barcelona
Tipo de actividad
Research Organisations
Contacto administrativo
Alexandre Puerto (Mr.)
Enlaces
Coste total
Sin datos